Dow Jones U.S. Pharmaceuticals Index

D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Phibro Animal (L, US)  Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals	88		5		48		44
2. Pfizer (XXL, US)  Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals	72		5		23		15
3. Supernus Pharma (M, US)  Pharmaceuticals
3. Supernus Pharma (M, US)   Pharmaceuticals	67		51		27		47
4. Akorn (M, US)  Pharmaceuticals
4. Akorn (M, US)   Pharmaceuticals	59		12		30		30
5. Assertio Therapeutics (S, US)  Pharmaceuticals
5. Assertio Therapeutics (S, US)   Pharmaceuticals	59		2		1		5
6. Amphastar (M, US)  Pharmaceuticals
6. Amphastar (M, US)   Pharmaceuticals	51		95		59		79
7. Lannett (M, US)  Pharmaceuticals
7. Lannett (M, US)   Pharmaceuticals	51		22		40		29

March 13, 2020. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Amphastar (M, US)   Pharmaceuticals
1. Amphastar (M, US)   Pharmaceuticals	51		95		59		79
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	33		88		9		36
3. Zoetis (XL, US)   Pharmaceuticals
3. Zoetis (XL, US)   Pharmaceuticals	16		84		23		37
4. Pacira BioSciences (M, US)   Pharmaceuticals
4. Pacira BioSciences (M, US)   Pharmaceuticals	8		84		16		33
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals	21		83		45		48
6. Catalent (L, US)   Pharmaceuticals
6. Catalent (L, US)   Pharmaceuticals	37		81		14		42
7. Supernus Pharma (M, US)   Pharmaceuticals
7. Supernus Pharma (M, US)   Pharmaceuticals	67		51		27		47

March 13, 2020. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Nektar (L, US)   Pharmaceuticals
1. Nektar (L, US)   Pharmaceuticals	1		1		80		14
2. Amphastar (M, US)   Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals	51		95		59		79
3. Phibro Animal (L, US)   Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals	88		5		48		44
4. Johnson & Johnson (XXL, US)   Pharmaceuticals
4. Johnson & Johnson (XXL, US)   Pharmaceuticals	16		26		47		8
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals	21		83		45		48

March 13, 2020. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Amphastar (M, US)   Pharmaceuticals
1. Amphastar (M, US)   Pharmaceuticals	51		95		59		79
2. Merck & Co. (XXL, US)   Pharmaceuticals
2. Merck & Co. (XXL, US)   Pharmaceuticals	21		83		45		48
3. Supernus Pharma (M, US)   Pharmaceuticals
3. Supernus Pharma (M, US)   Pharmaceuticals	67		51		27		47
4. Phibro Animal (L, US)   Pharmaceuticals
4. Phibro Animal (L, US)   Pharmaceuticals	88		5		48		44
5. Catalent (L, US)   Pharmaceuticals
5. Catalent (L, US)   Pharmaceuticals	37		81		14		42

March 13, 2020. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from March 13, 2020.